Last reviewed · How we verify
etonorgestrel
At a glance
| Generic name | etonorgestrel |
|---|---|
| Also known as | Nexplanon, Contraceptive implant |
| Sponsor | Karolinska Institutet |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Quick Start of Highly Effective Contraception
- A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED) (PHASE4)
- Patient Compliance With Long-Acting Reversible Contraception Administration (NA)
- Duration of Use of Highly Effective Reversible Contraception
- LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study (PHASE3)
- Quickstart of Nexplanon® at Medical Abortion (PHASE4)
- New Treatments for Troublesome Bleeding in Implanon Users (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |